Treatment and radiotherapy principle of limited-Hodgkin lymphoma:report in the 54th ASH annual meeting
10.3760/cma.j.issn.1009-9921.2013.05.001
- VernacularTitle:局限期霍奇金淋巴瘤的治疗及放疗原则:第54届美国血液学会年会报道
- Author:
Lei TIAN
;
Xiaoyan KE
- Publication Type:Journal Article
- Keywords:
Lymphoma,Hodgkin;
Radiotherapy;
Drug therapy;
ASH annual meeting
- From:
Journal of Leukemia & Lymphoma
2013;22(5):257-258
- CountryChina
- Language:Chinese
-
Abstract:
The limited-Hodgkin lymphoma (HL) treatment most preferred combined modality treatment,there are some scholars believe that nonbulky stage Ⅰ,Ⅱ of good prognosis HL patients,ABVD chemotherapy alone is acceptable,radiation therapy alone for stage Ⅰ or limited stage Ⅱ nodular lymphocytepredominant HL patients.Individual treatment by easing speed adjustment treatment in the future may make patients more benefit.
